Paris, France

Marie-Christine Dokhelar

This inventor holds 1 USPTO granted patent. Top assignees: Behringwerke Aktiengesellschaft, Dana-Farber-Cancer Institute Inc.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marie-Christine Dokhelar. Retrieved from https://idiyas.com/inventor/marie-christine-dokhelar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marie-Christine Dokhelar: Innovator in Cell Line Development

Introduction

Marie-Christine Dokhelar is a prominent inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of vectors for cell line establishment. Her work has implications for both research and therapeutic applications.

Latest Patents

Marie-Christine Dokhelar holds a patent for the H. saimiri-HTLV-X region vector. This innovative vector can be utilized to establish continuous cell lines of difficult-to-grow cells, such as human T-cells. Additionally, it can be employed to obtain specific cell products and in methods for screening new compounds. Her patent represents a valuable advancement in the field of cell biology.

Career Highlights

Throughout her career, Marie-Christine has worked with esteemed organizations, including the Dana-Farber Cancer Institute and Behringwerke Aktiengesellschaft. Her experience in these institutions has allowed her to contribute to groundbreaking research and development in cancer and cell biology.

Collaborations

Marie-Christine has collaborated with notable professionals in her field, including William A. Haseltine and Kathleen McGuire. These partnerships have further enhanced her research and innovation efforts.

Conclusion

Marie-Christine Dokhelar's contributions to biotechnology, particularly through her patent for the H. saimiri-HTLV-X region vector, highlight her role as a key innovator in the development of cell lines. Her work continues to influence research and therapeutic strategies in the life sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…